These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26478544)

  • 1. Direct oral anticoagulants: to switch or not to switch?
    Lugthart S; Leebeek FW
    Neth J Med; 2015 Oct; 73(8):359-61. PubMed ID: 26478544
    [No Abstract]   [Full Text] [Related]  

  • 2. When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?
    Boom MS; Berghuis EM; Nieuwkerk PT; Pinedo S; Büller HR
    Neth J Med; 2015 Oct; 73(8):368-72. PubMed ID: 26478546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
    Schurgers LJ; Spronk HM
    Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent changes in practice guidelines for atrial fibrillation management.
    Charneski L; Hollands JM
    Pharmacotherapy; 2014 Nov; 34(11):1118-20. PubMed ID: 25284056
    [No Abstract]   [Full Text] [Related]  

  • 6. Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
    Gaertner S; Cordeanu EM; Mirea C; Stephan D
    Int J Cardiol; 2015; 186():141-2. PubMed ID: 25818758
    [No Abstract]   [Full Text] [Related]  

  • 7. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
    Harenberg J; Bauersachs R; Ageno W
    Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Anticoagulation in Patients With Atrial Fibrillation.
    Moss JD; Cifu AS;
    JAMA; 2015 Jul; 314(3):291-2. PubMed ID: 26197190
    [No Abstract]   [Full Text] [Related]  

  • 9. [More with atrial fibrillation, anticoagulants since the coming of NOAK ].
    Forslund T; von Euler M; Johnsson H; Holmström M; Wettermark B; Hjemdahl P
    Lakartidningen; 2015 Jan; 112():. PubMed ID: 25584610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Sarinayova S; Heizmann M
    Praxis (Bern 1994); 2018 Jan; 107(3):145-151. PubMed ID: 29382262
    [No Abstract]   [Full Text] [Related]  

  • 12. Terminated.
    Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2014 Jun; 12(6):813. PubMed ID: 24916285
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials and tribulations.
    Greaves M
    J Thromb Haemost; 2014 Jun; 12(6):822-3. PubMed ID: 24655890
    [No Abstract]   [Full Text] [Related]  

  • 14. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials.
    Krishnamoorthy A; Sherwood MW; Lopes RD; Becker RC
    Am Heart J; 2015 Mar; 169(3):315-22. PubMed ID: 25728720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants.
    Haft JI
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):241-8. PubMed ID: 22952215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].
    Steurer J
    Praxis (Bern 1994); 2014 Jun; 103(13):785-6. PubMed ID: 24938162
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.
    Ghaffarpasand E; Tehrani MD; Marszalek J; Chi G
    J Thromb Thrombolysis; 2018 Oct; 46(3):332-338. PubMed ID: 29876713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into direct anticoagulants.
    Saad E; Dally N
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):492-8. PubMed ID: 25828968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.
    Di Minno MN; Russolillo A; Di Minno A; Camera M; Parolari A; Tremoli E
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):9-23. PubMed ID: 23448155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.